Context sidebar

Information

Latest News

 

Show all Announcements

26.06.2024

HPC – Credelio ad us. vet.

Zusätzliche Nebenwirkungen aus Erfahrungen nach dem Inverkehrbringen

15.06.2024

Simplification of requirements for renewed authorisation of medicinal products

Swissmedic has simplified the requirements for renewed authorisation of medicinal products

01.06.2024

Changes to the Guidance document Time limits for authorisation applications

The revised Guidance document Time limits for authorisation applications is valid with effect from 1 June 2024.

24.04.2024

HPC – Credelio ad us. vet.

Anpassung der Rubrik 4.6 «Nebenwirkungen» der Fachinformation

09.04.2024

HPC – Cimalgex ad us. vet., teilbare Tabletten für Hunde (Swissmedic 61525)

Polyurie, Polydipsie, schwerwiegende gastrointestinale und renale Nebenwirkungen

Publications

Vigilance for veterinary medicinal products Annual report 2021 (PDF, 1002 kB, 02.12.2022)

Top of page